Spironolactone

Comprehensive Product Overview

In clinical pharmacology, Spironolactone is distinguished by its specific mechanism as a competitive mineralocorticoid receptor antagonist. First, it binds to receptors in the distal renal tubules, blocking the effects of aldosterone. As a result, the body increases the excretion of water and sodium while significantly reducing the loss of potassium. Zyntex provides this API with a micronized particle size option, which is critical for overcoming its naturally low aqueous solubility and ensuring consistent absorption in tablet and suspension forms.

Zyntex also supplies Spironolactone for its increasingly important role in endocrinology and dermatology. Beyond its diuretic properties, it exhibits potent anti-androgenic activity by inhibiting the binding of dihydrotestosterone (DHT) to its receptors. In addition to treating primary hyperaldosteronism, it is widely utilized off-label for managing hormonal acne and hirsutism in female patients. Moreover, our production process ensures minimal related substances and impurities, which is vital for long-term chronic therapies. Consequently, our product helps manufacturers develop reliable treatments for both life-critical heart conditions and quality-of-life dermatological issues. Finally, our technical team provides extensive documentation to support your stability testing and regulatory submissions.

Key Pharmaceutical Applications

This versatile steroidal API is essential for the following therapeutic sectors:

Technical Specifications